Dysarthria

Etiology

Various neurological disorders can cause dysarthria. Dysarthria can arise from disorders at various locations of the neuroaxis, including the cerebral cortex, basal ganglia, cerebellum, cranial nerve nuclei, or peripheral nerves, and from a primary motor disorder of the tongue, larynx, and pharynx. Dysarthria is commonly categorized using the Mayo Clinic classification system, which divides dysarthria types by neuroanatomic locations (see Table 1, Mayo Clinic Classification).[4]

Table. Mayo Clinic Classification 

Dysarthria Etiologies

Underlying etiologies associated with dysarthria include:

• Infections: Creutzfeldt–Jakob disease, acquired immune deficiency disease
• Vascular disorder: ischemic and hemorrhagic strokes, arterio-venous malformations
• Neoplasm: primary and metastatic brain tumors
• Demyelinating: multiple sclerosis, Guillain–Barré disease
• Degenerative: Parkinson disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, Huntington disease, ataxia telangiectasia
• Trauma: Traumatic brain injury, chronic traumatic encephalopathy, cerebral palsy
• Toxic: heavy metal poisoning (Minamata disease due to methylmercury poisoning can cause dysarthria), alcohol, and drugs
• Genetic: sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO) due to a mutation in the gene encoding the mitochondrial DNA polymerase gamma enzyme (POLG1) [5][6]

In addition to the neurological causes, non-neurological causes, eg, cleft lip or palate and laryngeal tumors, also cause difficulty with articulation.

Epidemiology

The exact incidence of dysarthria is unknown, and it varies by underlying cause. About 90% of patients with Parkinson disease develop dysarthria during the illness. In ALS, dysarthria may predate limb weakness by about 3 to 5 years; it affects about 70% of patients with limb weakness.[7][8] In one study evaluating stroke patients, 28% had both aphasia and dysarthria, and 24% had dysarthria only. In a study of children with neuromuscular diseases, the prevalence of dysarthria was 31.5%.[9] An estimated 10% to 60% of patients with traumatic brain injury have dysarthria.[10]

Pathophysiology

The motor control of speech occurs at multiple levels. The cranial nerve nuclei receive cortical supply through the corticobulbar tract. Most cranial nerve motor nuclei receive bilateral corticobulbar input; key exceptions include the lower facial muscles (predominantly contralateral) and the genioglossus or tongue (often predominantly contralateral).

The facial nerve terminates in 5 branches; the branches that contribute to the muscles of speech are the buccal, mandibular, and, to an extent, cervical. The glossopharyngeal nerve (IX) provides motor innervation to the stylopharyngeus and contributes sensory innervation to the pharynx and posterior one-third of the tongue.[11] Stylopharyngeus elevates the pharynx during swallowing and speech and is motor-innervated by CN IX.

Through the pharyngeal branches, the vagus nerve innervates the pharyngeal muscles, which elevate the palate and cause pharyngeal constriction. The cricothyroid muscle, supplied by the vagus’ superior laryngeal branch, is the vocal cords’ chief tensor. The recurrent laryngeal nerve separates the vocal cords and opens the glottis through the posterior cricoarytenoids, closes the glottis through the lateral cricoarytenoids, and relaxes the vocal cords through the vocalis.

Hypoglossal nerve nuclei originating in the medulla provide motor branches to the tongue, supplying the intrinsic and extrinsic muscles (except the palatoglossus).

The following suprahyoid muscles influence tongue movements by altering the position of the hyoid bone:

• C1 fibers supply the geniohyoid muscle.
• The trigeminal nerve supplies the mylohyoid muscle and the anterior belly of the digastric muscle.
• The facial nerve supplies the stylohyoid muscle and the posterior belly of the digastric muscle.

In the neuromuscular junction, acetylcholine produced in the presynaptic nerve terminal binds to receptors, ultimately creating an endplate potential strong enough to propagate an action potential over the surface of the skeletal muscle membrane, resulting in muscle contraction. In myasthenia gravis, various autoantibodies interrupt these processes, resulting in dysarthria and other symptoms.[12]

History and Physical

Multiple neurological conditions cause dysarthria, so the natural course and clinical features can differ. The presentation can be acute in patients with acute ischemic stroke, whereas clinical manifestation can be delayed in neurodegenerative diseases like ALS.

Based on the Mayo classification, the following are salient features of dysarthria:

• Flaccid: Speech is slow, with hypernasality and breathy vocal quality. One of the most common examples in clinical practice is idiopathic peripheral facial paralysis, in which the patient presents with facial paralysis and drooling. Another common cause is Guillain–Barré syndrome.

• Spastic: Speech is harsh, with low pitch and constant errors. Speech evaluation shows hypernasality, reduced intelligibility, palatal elevation, and slow speech rate. Patients have signs of pseudobulbar palsy with dysphagia, hyperactive jaw jerk, and pseudobulbar affect. Patients with dysarthria-clumsy hand syndrome are noted to have facial weakness, dysarthria, and extremity dysmetria.[13]

• Hypokinetic dysarthria: This is seen in Parkinson disease due to the loss of dopaminergic neurons. Speech is monotone and poorly articulated, and tends to be quiet. Delays in speech initiation, mixed with rushing of words, can be seen. Other characteristic signs, eg, masked facial features, resting tremors, cogwheeling, and a festinating gait, can be observed on examination.

• Hyperkinetic dysarthria: This is seen with basal ganglia lesions and associated hyperkinetic movement disorders, such as HD. Speech is harsh, with variation in loudness and speech rate. There are occasional stoppages while speaking.

• Ataxic dysarthria: This presentation is commonly seen with disorders of the cerebellum or its connections. Speech has a “scanning” quality or irregular rhythm with the explosion of syllables. Prosody is impaired, with each syllable being pronounced slowly, and there is a pause after every syllable. There is decreased motor coordination manifested by axial and appendicular ataxia, depending on the part of the cerebellum affected.

• Mixed dysarthria: Two or more central nervous system components are affected in this type. This can be seen with ALS and multiple sclerosis. Speech is slow, prosody is disrupted, voice is strained, and there is marked hypernasality.[14]

Evaluation

A thorough history and detailed physical examination play a critical role in evaluating patients presenting with dysarthria. A comprehensive initial speech evaluation includes 5 components: history, oral-motor and speech-mechanism examination, screening of subsystems (respiration, phonation, articulation, resonance, and prosody), perceptual assessment, and intelligibility evaluation. These elements together provide a structured framework for identifying deficits, guiding further testing, and informing individualized management plans.

The water glass manometer test offers a gross assessment of pressure-generating capabilities for speech production. During the test, the patient blows into a water-filled drinking glass with the straw secured at a specific depth. Maintaining a stream of bubbles for 5 seconds indicates adequate breath support for most speech functions. Valid results require the patient to sustain velopharyngeal closure and a tight lip seal around the straw.[15]

Perceptual assessment of speech allows observation of all speech subsystems in real time, providing insight into functional deficits and serving as a tool for comparison over time. Reading passages, eg, "my grandfather" and the "Caterpillar Passage," facilitate evaluation of the speech repertoire, subsystem function, contemporary vocabulary, simple syntax, and polysyllabic word production.[16][17] These tools support detailed analysis of speech performance and inform targeted therapeutic interventions.

The Caterpillar Passage

The "Caterpillar Passage" patients are to read is as follows:

Do you like amusement parks? Well, I sure do. To amuse myself, I went twice last spring. My most MEMORABLE moment was riding on the Caterpillar, which is a gigantic roller coaster high above the ground. When I saw how high the Caterpillar rose into the bright blue sky, I knew it was for me. After waiting in line for 30 minutes, I reached the front, where the man measured my height to see if I was tall enough. I gave the man my coins, asked for change, and jumped on the cart. Tick, tick, tick, the Caterpillar climbed slowly up the tracks. It went SO high I could see the parking lot. Boy, was I SCARED! I thought to myself, "There's no turning back now." People were so scared they screamed as we zoomed fast and faster along the tracks. As quickly as it started, the Caterpillar came to a stop. Unfortunately, it was time to pack the car and drive home. That night, I dreamt of the wild ride on the Caterpillar. Taking a trip to the amusement park and riding on the Caterpillar was my MOST memorable moment ever! 

Speech Intelligibility Evaluation

Assessment of speech intelligibility in dysarthric speakers relies on tools, eg, the Assessment of Intelligibility in Dysarthric Speakers (AIDS), the Sentence Intelligibility Test (SIT), and word-intelligibility tests. The AIDS tool remains the most commonly used and includes both word and sentence tasks. During the word task, the patient reads or imitates 50 words selected at random from a set of 12 phonetically similar options. In the sentence task, the patient reads or imitates 2 sentences for each of 220 words, selected from a pool of 100 sentences of varying lengths. A trained evaluator determines an intelligibility score based on the percentage of words accurately transcribed. The SIT tool is an enhanced Windows-based version of the sentence component of the AIDS tool, evaluating intelligibility at both the word and sentence levels while also estimating communication efficiency by measuring the number of intelligible words produced per minute.

Clinical history and symptom progression provide critical diagnostic clues. Onset and evolution of dysarthria, along with associated neurologic features, eg, tremors, dysphagia, and gait instability, guide etiologic considerations. Medication review should address potential overdoses and toxin exposure, including alcohol and cocaine. Bedside assessment techniques include counting from 1 to 100 to elicit respiratory muscle fatigue in myasthenia gravis and counting from 1 to 30 without interruption to evaluate respiratory function.[18] Sustained phonation of an "ah" sound serves as a practical test of laryngeal function.

Diagnostic evaluation frequently incorporates imaging modalities, eg, computed tomography (CT) of the head and magnetic resonance imaging (MRI) of the brain. Suspected neuromuscular junction disorders warrant electromyography (EMG) and nerve conduction studies. Laboratory investigations, including a complete blood count, a basic metabolic profile, and a urine drug screening, should align with the clinical history and pretest probability. In cases of suspected Guillain–Barré syndrome, pulmonary function testing, including measurement of vital capacity and negative inspiratory force, remains essential.[18]

Speech Assessment Tools

Speech assessment tools further refine the evaluation of dysarthria. The Frenchay Dysarthria Assessment, widely used in clinical practice, was introduced in 1980 and revised in 2008. This tool includes a structured series of tasks designed to classify dysarthria subtypes. Speech-language pathologists rate performance using a 5-point scale across domains, including reflexes, respiration, lips, palate, laryngeal function, tongue, intelligibility, and influencing factors.[19] Subjective assessment may incorporate self-report instruments, eg, Living with Neurologically Based Speech Difficulties (Living with Dysarthria, LwD). Perceived communication challenges do not always correlate with measured severity, highlighting the importance of patient-centered evaluation.[20] 

Artificial Intelligence Assessments

Advances in artificial intelligence (AI) have introduced new approaches to speech assessment. AI-driven models now support objective severity estimation and prediction of speech intelligibility, offering scalable and reproducible alternatives to clinician-dependent evaluations.[21][22] Machine learning applications demonstrate strong performance in predicting listener effort in amyotrophic lateral sclerosis–related dysarthria.[21]

Automated detection and severity classification systems enable earlier intervention and more personalized management strategies. A hybrid deep learning framework integrating Convolutional Neural Networks, Bidirectional Long Short-Term Memory, and Transformer architectures, evaluated on publicly available speech datasets, achieved detection accuracies of 98.74% and 99.86% and severity classification accuracies of 95.69% and 97.91%, respectively.[23]

Treatment / Management

The primary goals of speech and language treatment include the restoration of effective communication, the development of compensatory strategies for communication impairments, and the education of individuals within the patient’s environment regarding assistive communication supports. These efforts promote improved interaction, reduce social isolation, and address the patient’s functional needs and personal preferences.

Treatment planning requires careful consideration of the underlying cause, severity, and associated comorbidities of dysarthria. Speech-language pathologists and physicians collaborate to design an individualized management approach tailored to each patient. Current evidence demonstrates that speech rehabilitation leads to significant improvement in communication outcomes among adults with stroke-related dysarthria. Interventions, eg, Lee Silverman Voice Treatment, have also shown effectiveness in improving speech in individuals with hypokinetic dysarthria associated with Parkinson disease.[24][25](A1)

Broadly, types of therapy could be grouped as follows:

• Therapy targeting the speech-production subsystems
• Communication strategies
• Environmental adaptations
• Augmentative and alternative communication (AAC)
• Medical/surgical interventions.

Targeting the Speech-Production Subsystems

Speech-language pathologists can target 5 key subcomponents involved in speech production to improve communication outcomes. Interventions directed at phonation include Lee Silverman Voice Treatment and Pitch Limiting Voice Treatment. Lee Silverman Voice Treatment enhances vocal loudness and intelligibility and has undergone extensive study in Parkinson disease, whereas Pitch Limiting Voice Treatment increases vocal loudness without altering pitch.[26][27]

A landmark 2024 study demonstrated that Lee Silverman Voice Treatment improved dysarthria more effectively than standard speech therapy in patients with Parkinson disease.[28] Articulatory precision improves through strategies, eg, increasing loudness, incorporating pauses, exaggerating articulation, and modifying pitch variation. Respiratory muscle strength training enhances breath support by optimizing posture and targeting respiratory function.(A1)

Communication Strategies

Effective communication strategies involve both the communication partner and the patient. Partners can support communication by providing feedback, clarifying messages, and offering encouragement. Patients benefit from initiating conversations by gaining their partner’s attention, speaking more slowly, repeating phrases as needed, and incorporating nonverbal cues such as eye contact and facial expressions.

Speech supplementation strategies include alphabet, syntactic, and topic supplementation. Alphabet supplementation involves using an alphabet board to indicate the initial letter of a word. Topic supplementation uses a cue word or phrase before speech to provide context. Syntactic supplementation conveys grammatical or word-class information alongside each spoken word. Behavioral communication interventions, including biofeedback, demonstrate measurable improvements in speech intelligibility. In patients with stroke, biofeedback techniques have increased vocal intensity, reduced speech rate, and enhanced overall intelligibility.[29][30]

Environmental Adaptations

Setting up optimal environmental conditions to increase understandability includes ensuring a quiet conversation background, intimate seating, and face-to-face interaction.

Augmentative and Alternative Communication

Augmentative and alternative communication (AAC) may include low-tech aids, eg, picture boards or pen and paper, or high-tech aids, eg, smartphones, voice synthesizers, digital records, and speech-generating devices.[31] 

Computer-based interventions offer an exciting step toward dysarthria management, including:

1. A mobile application for patients with Parkinson disease, comprising an assessment of the speech in addition to various other aspects of disease management.[32] Similar smartphone-based speech therapy has shown promising results in improving poststroke dysarthria.[33]
2. Feedback and individual computer-based practice were as effective as traditional therapy for patients with stable dysarthria.[34]
3. Improvement in articulation and intelligibility was assessed in virtual articulation therapy.[35]
(A1)

These small studies hold good promise for further expansion of computer-based interventions.

Medical and Surgical Interventions

Medical management should focus on the underlying neurologic etiology. In dysarthria associated with Parkinson disease, treatment emphasizes optimization of dopaminergic therapy, although medication effects on speech remain variable. Subthalamic nucleus stimulation demonstrates some benefit among surgical interventions; however, many procedures, including this approach, may worsen speech intelligibility in Parkinson disease.[36] Management of spasticity in amyotrophic lateral sclerosis has included agents, eg, baclofen, tizanidine, and botulinum toxin type A.[8]

Surgical interventions may address specific structural or functional deficits. Laryngoplasty serves as a treatment option for persistent hoarseness related to recurrent laryngeal nerve palsy that fails to improve with conservative measures. A palatal lift enhances resonance by elevating a weakened palate. The expansion of telehealth following the 2019 COVID-19 pandemic has increased access to care. Telerehabilitation offers a cost-effective alternative to traditional rehabilitation and demonstrates comparable effectiveness in improving functional outcomes after stroke, including speech.[37] Speech therapy delivered through teletherapy platforms in patients with Parkinson disease has been associated with increased patient satisfaction, largely due to improved convenience and accessibility. Interpretation of these findings requires caution, as available studies demonstrate heterogeneity in protocols and lack double-blinding.[38] 

Noninvasive Brain Stimulation

Noninvasive brain stimulation has emerged as a promising adjunctive modality in the management of Parkinson disease by modulating cortical excitability and promoting neuroplastic reorganization. Repetitive transcranial magnetic stimulation shows therapeutic potential in improving both speech and motor function, with evidence suggesting enhanced auditory–motor integration that contributes to improved phonatory control, articulatory precision, and overall speech intelligibility.[39][40][41] Additionally, transcranial direct current stimulation delivers low-intensity electrical current through scalp electrodes to modulate cortical activity in a polarity-dependent manner, influencing neuronal function and plasticity. Preliminary pilot studies suggest potential benefits of these techniques in improving dysarthria among patients with post-stroke conditions.[42][43](A1)

Neuromuscular Electrical Stimulation

Neuromuscular electrical stimulation devices activate motor nerves to produce muscle contractions. This approach recruits motor units in a relatively synchronous manner by stimulating peripheral structures beneath the electrodes, supporting long-term improvements in neuromuscular performance, including increased muscle strength, enhanced fatigue resistance, improved functional movement, and better muscle quality for rehabilitation and training.[44](B3)

Differential Diagnosis

Differential diagnoses for dysarthria include aphasia, apraxia of speech, and aphemia, each with distinct clinical features that aid diagnostic clarification. Apraxia of speech represents a disorder of learned motor planning in which patients experience difficulty initiating speech and transitioning between sounds. Speech production often occurs through trial and error, with inconsistent articulation errors across repeated attempts. Repetition tasks, particularly involving polysyllabic words, eg, “television,” reveal variable errors with each attempt. Isolated apraxia of speech is infrequent and often occurs concurrently with aphasia. Neuroimaging may demonstrate lesions involving the dominant insula and Broca area.[45]

Aphasia constitutes a disorder of language processing in which deficits affect comprehension, expression, or both, depending on lesion location. Patients frequently exhibit impairments in reading and writing, in addition to difficulties with spoken language.[46] Aphemia describes a motor speech disorder characterized by near muteness. Despite markedly reduced speech output, patients retain intact comprehension, reading, and writing abilities.

Prognosis

Dysarthria may be persistent or progressive depending on the underlying etiology. Dysarthria is generally considered stable in nonprogressive etiologies (eg, a static brain injury) and progressive in many neurodegenerative disorders

Recovery also appears to be dependent on the etiology. One study evaluating dysarthria following stroke showed recovery in about half of the patients.[47] No long-term prognosis estimates for various diseases are available. However, from various anecdotal reports, evidence demonstrates that dysarthria is progressive in most neurodegenerative diseases. Functional Communication Measures (FCMs) are rating scales used to assess an individual’s functional abilities. These 7-point rating scales range from least functional (level 1) to most functional (level 7) and help measure a patient’s functional communication and swallowing abilities throughout speech-language pathology intervention.

Complications

Speech impairment exerts a profound effect on psychosocial well-being. Patients frequently report stigmatization, altered self-identity, and significant social and emotional disturbances associated with poststroke dysarthria. In pediatric populations, behavioral challenges and limited access to education contribute to reduced future employment opportunities. Tools, eg, the Dysarthria Impact Profile, support evaluation of these psychosocial effects.[48] Recognition of these broad consequences underscores the importance of timely and targeted intervention.

The Dysarthria Impact Profile provides a structured method for assessing psychosocial burden by capturing patient-reported challenges in everyday situations, including interactions with unfamiliar individuals and tasks such as ordering a meal at a restaurant. Clinicians use this instrument for both outcome measurement and intervention planning.[49] The Communicative Participation Item Bank serves as a self-report measure for adults with communication disorders and supports both clinical practice and research.[50] This tool similarly captures the extent to which communication limitations affect participation in routine social contexts, including conversations with unfamiliar individuals and community interactions.